Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Johnathan K, Joffe"'
Autor:
Johnathan K, Joffe, Fay H, Cafferty, Laura, Murphy, Gordon J S, Rustin, Syed A, Sohaib, Rhian, Gabe, Sally P, Stenning, Elizabeth, James, Dipa, Noor, Simona, Wade, Francesca, Schiavone, Sarah, Swift, Elaine, Dunwoodie, Marcia, Hall, Anand, Sharma, Jeremy, Braybrooke, Jonathan, Shamash, John, Logue, Henry H, Taylor, Ivo, Hennig, Jeff, White, Sarah, Rudman, Jane, Worlding, David, Bloomfield, Guy, Faust, Hilary, Glen, Rachel, Jones, Michael, Seckl, Graham, MacDonald, Thiagarajan, Sreenivasan, Satish, Kumar, Andrew, Protheroe, Ramachandran, Venkitaraman, Danish, Mazhar, Victoria, Coyle, Martin, Highley, Tom, Geldart, Robert, Laing, Richard S, Kaplan, Robert A, Huddart
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 40(22)
PURPOSE Survival in stage I seminoma is almost 100%. Computed tomography (CT) surveillance is an international standard of care, avoiding adjuvant therapy. In this young population, minimizing irradiation is vital. The Trial of Imaging and Surveillan
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::32509283fdd8f055e025757fc245aebc
https://pubmed.ncbi.nlm.nih.gov/35298280
https://pubmed.ncbi.nlm.nih.gov/35298280
Autor:
Dacheng Huo, Robert A Huddart, Fay Helen Cafferty, Laura Murphy, Gordon J. S. Rustin, Syed A Sohaib, Francesca Schiavone, Richard S. Kaplan, Johnathan K Joffe, Mark Sculpher, Saramago Pedro
Publikováno v:
Journal of Clinical Oncology. 41:408-408
408 Background: Risk of radiation exposure from standard computed tomography (CT) surveillance is a major concern in the management of stage I seminoma testis patients. The TRISST randomized trial (NCT00589537) demonstrated that effective monitoring
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e42f94208583bc53c3f844ecada33ca5
https://doi.org/10.1200/jco.2023.41.6_suppl.408
https://doi.org/10.1200/jco.2023.41.6_suppl.408
Autor:
Lawrence H. Einhorn, Abdel-Baset Halim, Hamim Zahir, David I. Quinn, Yohann Loriot, Johnathan K. Joffe, Robert J. Motzer, Darren R. Feldman, Aude Flechon, Julio Hajdenberg, David J. Vaughn
Publikováno v:
Investigational New Drugs. 31:1016-1022
Background Tivantinib is a selective, small-molecule inhibitor of the MET receptor tyrosine kinase. Preclinical and phase 1 data suggested a possible role for MET in the pathophysiology of germ cell tumors (GCTs) and a potential clinical benefit from
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::199622ffc02a1b853270d2fbf0ce1ee4
https://doi.org/10.1007/s10637-013-9934-y
https://doi.org/10.1007/s10637-013-9934-y
Autor:
N. Nicolai, O. Leiva, Johnathan K Joffe, O. Klepp, P. Walz, Rolf Mueller, M. de Wit, S. Clemm, S. D. Fossa, Niels E. Skakkebæk, Gedske Daugaard, Robert Huddart, S. Tjulandin, M. Kuczyk, S. Krege, M. D. Mason, G. Kaiser, X. Garcia del Muro, László Kisbenedek, Gosse O N Oosterhof, O. Rick, Wolfgang Hoeltl, S. Kliesch, H. von der Maase, M. Bamberg, A. Gerl, N. Aass, Christian Kollmannsberger, G. Pizzocaro, M. Hartmann, L. Weissbach, O. Pont, U. Studer, P. Albers, M.P. Laguna, V. Loy, R. Souchon, H.-J. Schmoll, J. P. Droz, P.H.M. de Mulder, Heinz Schmidberger, Jörg Beyer, K. Fizazi, Tobias Pottek, J. Classen, G. M. Mead, Alan Horwich, L. Paz Ares, C. Bokemeyer, W. Jones, Eva Winter, T. Oliver, H. G. Derigs, J. R. Germa-Lluch, Felix Sedlmayer, István Bodrogi, Stefan Weinknecht, M. Flasshove, A. Heidenreich, F. Algaba, R. de Wit, S. Culine, K. U. Koehrmann, C. Wittekind, J. T. Hartmann, K. P. Dieckmann, W. Siegert, G. Rosti
Publikováno v:
Annals of Oncology, 15, 9, pp. 1377-99
Annals of Oncology, 15, 1377-99
Annals of Oncology, 15, 1377-1399. Elsevier Ltd.
Schmoll, H J, Souchon, R, Krege, S, Albers, P, Beyer, J, Kollmannsberger, C, Fossa, S D, Skakkebaek, N E, de Wit, R, Fizazi, K, Droz, J P, Pizzocaro, G, Daugaard, G, de Mulder, P H, Horwich, A, Oliver, T, Huddart, R, Rosti, G, Paz Ares, L, Pont, O, Hartmann, J T, Aass, N, Algaba, F, Bamberg, M, Bodrogi, I, Bokemeyer, C, Classen, J, Clemm, S, Culine, S, de Wit, M, Derigs, H G, Dieckmann, K P, Flasshove, M, Garcia del Muro, X, Gerl, A, Germa-Lluch, J R, Hartmann, M, Heidenreich, A, Hoeltl, W, Joffe, J, Jones, W, Kaiser, G, Klepp, O, Kliesch, S, Kisbenedek, L, Koehrmann, K U, Kuczyk, M, Laguna, M P, Leiva, O, Loy, V, Mason, M D, Mead, G M, Mueller, R P, Nicolai, N, Oosterhof, G O, Pottek, T, Rick, O, Schmidberger, H, Sedlmayer, F, Siegert, W, Studer, U, Tjulandin, S, Maase, H V D, Walz, P, Weinknecht, S, Weissbach, L, Winter, E & Wittekind, C 2004, ' European consensus on diagnosis and treatment of germ cell cancer : A report of The European Germ Cell Cancer Consensus Group (EGCCCG) ', European Urology, vol. 15, pp. 1377-1399 .
Annals of Oncology, 15, 1377-99
Annals of Oncology, 15, 1377-1399. Elsevier Ltd.
Schmoll, H J, Souchon, R, Krege, S, Albers, P, Beyer, J, Kollmannsberger, C, Fossa, S D, Skakkebaek, N E, de Wit, R, Fizazi, K, Droz, J P, Pizzocaro, G, Daugaard, G, de Mulder, P H, Horwich, A, Oliver, T, Huddart, R, Rosti, G, Paz Ares, L, Pont, O, Hartmann, J T, Aass, N, Algaba, F, Bamberg, M, Bodrogi, I, Bokemeyer, C, Classen, J, Clemm, S, Culine, S, de Wit, M, Derigs, H G, Dieckmann, K P, Flasshove, M, Garcia del Muro, X, Gerl, A, Germa-Lluch, J R, Hartmann, M, Heidenreich, A, Hoeltl, W, Joffe, J, Jones, W, Kaiser, G, Klepp, O, Kliesch, S, Kisbenedek, L, Koehrmann, K U, Kuczyk, M, Laguna, M P, Leiva, O, Loy, V, Mason, M D, Mead, G M, Mueller, R P, Nicolai, N, Oosterhof, G O, Pottek, T, Rick, O, Schmidberger, H, Sedlmayer, F, Siegert, W, Studer, U, Tjulandin, S, Maase, H V D, Walz, P, Weinknecht, S, Weissbach, L, Winter, E & Wittekind, C 2004, ' European consensus on diagnosis and treatment of germ cell cancer : A report of The European Germ Cell Cancer Consensus Group (EGCCCG) ', European Urology, vol. 15, pp. 1377-1399 .
Germ cell tumour is the most frequent malignant tumour type in young men with a 100% rise in the incidence every 20 years. Despite this, the high sensitivity of germ cell tumours to platinum-based chemotherapy, together with radiation and surgical me
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::03402bbd11b08d48e88c2f718a1ae54e
https://doi.org/10.1093/annonc/mdh301
https://doi.org/10.1093/annonc/mdh301
Autor:
Kate, Collinson, Matthew J, Murray, Nicolas M, Orsi, Michele, Cummings, Janet, Shipley, Johnathan K, Joffe, Nicholas, Coleman, Daniel, Stark
Publikováno v:
Genes, chromosomescancer. 53(3)
Germ cell tumors (GCTs) are rare but clinically and pathologically diverse tumors that occur in an extensive range of age groups, from children to older adults and which include both seminomatous and nonseminomatous tumors. Current clinical managemen
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::13eea749aaf87f05f6963a9beb003809
https://pubmed.ncbi.nlm.nih.gov/24311530
https://pubmed.ncbi.nlm.nih.gov/24311530
Autor:
Paul Vasey, Gedske Daugaard, Anwar R. Padhani, Robert Huddart, Sally P. Stenning, Gordon J. S. Rustin, Jane E. Mackewn, Johnathan K Joffe, GM Mead, Michael O'Doherty, S. J. Harland, S F Hain, John P Logue, SJ Kirk
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 25(21)
Purpose There are several management options for patients with clinical stage I (CS1) nonseminomatous germ cell tumors (NSGCT); this study examined whether an 18fluorodeoxyglucose positron emission tomography (18FDG PET) scan could identify patients
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1beba88b4d85736a2421fe8658a65f4f
https://pubmed.ncbi.nlm.nih.gov/17634488
https://pubmed.ncbi.nlm.nih.gov/17634488